Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study (Q37282589)
Jump to navigation
Jump to search
scientific article published on 02 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study |
scientific article published on 02 March 2016 |
Statements
1 reference
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study (English)
1 reference
Kazunari Murakami
1 reference
Yuuichi Sakurai
1 reference
Madoka Shiino
1 reference
Nobuo Funao
1 reference
Akira Nishimura
1 reference
Masahiro Asaka
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference